English

Eligibility Non-Small-Cell Lung Carcinoma NCT00256711

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed nsclc and willing to provide paraffin embedded tumour tissue
Description

Non-Small Cell Lung Carcinoma | Tumor tissue Paraffin Embedded Providing

Data type

boolean

Alias
UMLS CUI [1]
C0007131
UMLS CUI [2,1]
C0475358
UMLS CUI [2,2]
C1519524
UMLS CUI [2,3]
C1999230
nsclc - locally advanced (stage iiib) or metastatic (stage iv) disease, not amenable to curative surgery or radiotherapy chemonaïve, life expectancy of 12 weeks
Description

Non-Small Cell Lung Carcinoma Advanced Locally | Non-small cell lung cancer metastatic | TNM clinical staging | Disease Amenable Curative Surgery | Disease Amenable Chemoradiotherapy naive | Life Expectancy

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C1517927
UMLS CUI [2]
C0278987
UMLS CUI [3]
C3258246
UMLS CUI [4,1]
C0012634
UMLS CUI [4,2]
C3900053
UMLS CUI [4,3]
C1511562
UMLS CUI [5,1]
C0012634
UMLS CUI [5,2]
C3900053
UMLS CUI [5,3]
C0436307
UMLS CUI [5,4]
C0919936
UMLS CUI [6]
C0023671
who performance status <= 2
Description

WHO performance status scale

Data type

boolean

Alias
UMLS CUI [1]
C1298650
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
newly diagnosed cns metastases
Description

CNS metastases

Data type

boolean

Alias
UMLS CUI [1]
C0686377
less than 4 weeks since completion of radiotherapy or persistence of any radiotherapy related toxicity.
Description

Therapeutic radiology procedure Complete | Toxic effect persistent Therapeutic radiology procedure Related

Data type

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0205197
UMLS CUI [2,1]
C0600688
UMLS CUI [2,2]
C0205322
UMLS CUI [2,3]
C1522449
UMLS CUI [2,4]
C0439849
hypersensitivity to zd1839 or intravenous vinorelbine
Description

Hypersensitivity ZD1839 | Hypersensitivity vinorelbine Intravenous

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0879396
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0078257
UMLS CUI [2,3]
C1522726
prior treatment with egfr inhibitors
Description

Epidermal growth factor receptor inhibitor

Data type

boolean

Alias
UMLS CUI [1]
C1443775
other co-existing malignancies
Description

Malignant Neoplasms

Data type

boolean

Alias
UMLS CUI [1]
C0006826
alt/ast >2.5 x ulrr
Description

Alanine aminotransferase measurement | Aspartate aminotransferase measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
anc < 2.0 x 10^9/l or platelets < 100 x 10^9/l
Description

Absolute neutrophil count | Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
Back to the top of the page

Similar models

Eligibility Non-Small-Cell Lung Carcinoma NCT00256711

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma | Tumor tissue Paraffin Embedded Providing
Item
histologically confirmed nsclc and willing to provide paraffin embedded tumour tissue
boolean
C0007131 (UMLS CUI [1])
C0475358 (UMLS CUI [2,1])
C1519524 (UMLS CUI [2,2])
C1999230 (UMLS CUI [2,3])
Non-Small Cell Lung Carcinoma Advanced Locally | Non-small cell lung cancer metastatic | TNM clinical staging | Disease Amenable Curative Surgery | Disease Amenable Chemoradiotherapy naive | Life Expectancy
Item
nsclc - locally advanced (stage iiib) or metastatic (stage iv) disease, not amenable to curative surgery or radiotherapy chemonaïve, life expectancy of 12 weeks
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C0278987 (UMLS CUI [2])
C3258246 (UMLS CUI [3])
C0012634 (UMLS CUI [4,1])
C3900053 (UMLS CUI [4,2])
C1511562 (UMLS CUI [4,3])
C0012634 (UMLS CUI [5,1])
C3900053 (UMLS CUI [5,2])
C0436307 (UMLS CUI [5,3])
C0919936 (UMLS CUI [5,4])
C0023671 (UMLS CUI [6])
WHO performance status scale
Item
who performance status <= 2
boolean
C1298650 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
CNS metastases
Item
newly diagnosed cns metastases
boolean
C0686377 (UMLS CUI [1])
Therapeutic radiology procedure Complete | Toxic effect persistent Therapeutic radiology procedure Related
Item
less than 4 weeks since completion of radiotherapy or persistence of any radiotherapy related toxicity.
boolean
C1522449 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0600688 (UMLS CUI [2,1])
C0205322 (UMLS CUI [2,2])
C1522449 (UMLS CUI [2,3])
C0439849 (UMLS CUI [2,4])
Hypersensitivity ZD1839 | Hypersensitivity vinorelbine Intravenous
Item
hypersensitivity to zd1839 or intravenous vinorelbine
boolean
C0020517 (UMLS CUI [1,1])
C0879396 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0078257 (UMLS CUI [2,2])
C1522726 (UMLS CUI [2,3])
Epidermal growth factor receptor inhibitor
Item
prior treatment with egfr inhibitors
boolean
C1443775 (UMLS CUI [1])
Malignant Neoplasms
Item
other co-existing malignancies
boolean
C0006826 (UMLS CUI [1])
Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
alt/ast >2.5 x ulrr
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
Absolute neutrophil count | Platelet Count measurement
Item
anc < 2.0 x 10^9/l or platelets < 100 x 10^9/l
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
Back to the top of the page